Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Low-Phosphate Diet on Fibroblast Growth Factor-23 Level in Patients Undergoing Hemodialysis

NCT03367338 is registered in ClinicalTrials.gov with Wan-Chuan Tsai as lead sponsor.

NCT NCT03367338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Low-Phosphate Diet on Fibroblast Growth Factor-23 Level in Patients Undergoing Hemodialysis
Lead sponsor
Wan-Chuan Tsai
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2018
Completion date
June 8, 2018
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring chronic dialysis, dietary intervention, elevated fibroblast growth factor-23, hyperphosphatemia